Introduction
Detailing the structure and function of the various animal toxins provides several interesting research avenues in terms of protein engineering and therapeutic potential (Ménez, 1998; Gilquin et al., 2003; Lewis & Garcia, 2003) . First, it appears pivotal to unravel the molecular determinants by which structurally specific animal toxins are able to recognize, often with high affinity, the diverse ion channel types if one plans to benefit from their pharmacological properties. Because toxins generally display a large array of ion channel targets of which only one may be of therapeutic value (e.g., K v 1.3 as therapeutic target for immune suppression) (Kem et al., 1999) , a detailed examination of their folds and molecular determinants represents a way to act on their pharmacological selectivity, specificity and potency. Though this identification step of the toxin molecular determinants is crucial, it reveals itself a complex task with regard to the diversity of toxin folds so far identified.
Second, toxins are structured by a high number of disulfide bridges (from two to five) as compared to their backbone length, thereby conferring some rigidity to the molecules, a stabilization of their secondary structures, as well as a relative resistance to denaturation (heat, acid/alkali, detergents, etc…) . Despite this peptide rigidity, there are some flexible domains, more or less conserved, that could be diverted from their regular molecular rolessuch as ion channel recognition -for protein engineering purposes (Ménez, 1998) . A better grasp on toxin folds should therefore offer valuable perspectives in the use of toxins as templates to engineer molecules with novel biological functions. In this respect, stability and potency are toxin properties that appear particularly important to maintain. Indeed, toxins are stable enough to resist fairly well to degradation by proteases present in both venoms and target tissues. Altogether, these toxin properties should make them a unique source of lead compounds and templates (Gilquin et al., 2003) from which agents of specific therapeutic value may be designed and generated.
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Here, the families of folds for animal toxins acting on ion channels of different selectivities were reviewed in order to illustrate the structural diversity of this class of highly potent natural molecules. We were able to identify no less than eight different types of fold for toxins active on K + channels, eight types for Na + channels, four types for Ca 2+ channels and a single type for Cl -channels. Of note, we chose to classify the toxin folds according to ion channel selectivity rather than channel structural homology for convenience of data presentation, although some toxin folds could act on channels presenting differences in ionic selectivity (Chuang et al., 1998; Olamendi-Portugal et al., 2002) . Though there are several toxin folds, none is definitively associated to a particular animal species or ion channel selectivity (Ménez, 1998) . As an example, it has been evidenced that toxins acting on K + channels, structured according to either αα, αββ or βαββ type of fold (see classification below), exist in scorpion venoms (Srinivasan et al., 2002; Blanc et al., 1997; Bontems et al., 1992) .
I-Folds of toxins acting on K + channels
Animal toxins acting on K + channels have been isolated from the venoms of numerous animal species, such as marine cone snails, spiders, scorpions, sea anemones and snakes (Possani et al., 1999b; Fletcher et al., 1999; Kem et al., 1999) . The toxins characterized hitherto contain between 22 and 60 amino acid residues and can be cross-linked by two to four disulfide bridges. As shown in Figure 1 , we have classified these reference toxins into eight categories depending on their types of fold (Scanlon et al., 1997; Srinivasan et al., 2002; Dauplais et al., 1997; Tudor et al., 1996; Takahashi et al., 2000; Blanc et al., 1997; Bontems et al., 1992; Lancelin et al., 1994) . These folds contain from two to four well-defined elements of secondary structure, and range from a combination of β-strands (βββ type of fold - see the marine cone snail toxin κ-PVIIA ( Figure 1a ; Scanlon et al., 1997 & Savarin et al., et al., 2002) and sea anemone BgK ( Figure 1c ; Dauplais et al., 1997) ), and one 3 10 αα typesee sea anemone ShK (Figure 1d ; Tudor et al., 1996) , or a mixture of both secondary structures (3 10 ββ, αββ, βαββ, and 3 10 ββα types -examples illustrated are spider hanatoxin 1 (Takahashi et al., 2000) , scorpion maurotoxin (Blanc et al., 1997) , scorpion charybdotoxin (Bontems et al., 1992) , and snake dendrotoxin I (Lancelin et al., 1994) (Figure 1e-h) ). As mentioned, there are some variants in a same combination of secondary structures. Indeed, the αα type of fold can be subdivided into two families: (i) the so-called "helical hairpin-like" motif in which two α-helices are arranged in an anti-parallel manner (Srinivasan et al., 2002) , and (ii) the "helical cross-like" motif in which one α-helix is disposed perpendicular to the other (Dauplais et al., 1997) . The more complex 3 10 αα arrangement is also referred to as the "helical capping" motif since one α-helix caps the other two helical structures (Tudor et al., 1996) . Finally, the αββ (Blanc et al., 1997) and βαββ (Bontems et al., 1992) types of fold differ by the addition of a β-strand at the N-terminal end of the toxin, whereas the 3 10 ββ (Takahashi et al., 2000) and 3 10 ββα (Lancelin et al., 1994) types of fold differ from each other by the presence of an α-helix at the peptide C-terminal extremity. The αββ and βαββ types have been commonly regrouped under the architectural motif denomination of α/β scaffold (Bontems et al., 1991) , i.e., a helical structure connected to a β-sheet by two disulfide bridges. The βββ and 3 10 ββ types have been associated with the "Inhibitor Cystine
Knot" (ICK) architectural motif (Pallaghy et al., 1994) . The latter consists of a ring of residues formed by disulfide bridges C1-C4 and C2-C5, through which a third disulfide bridge (C3-C6) penetrates to form a cystine knot. Of note, ββ and βββ3 10 types of fold (Peng et al., 2002; Fletcher et al., 1997) -presented in later sections -are also associated with the 7 supplementary disulfide bridge is formed either in one of the loops, or between a loop and the C-terminal extremity. Such a motif is extremely stable and behaves as an adequate scaffold from which the side chains of functionally important residues can protrude to produce multiple bioactivities by varying the inter-cystine residues of each loop.
The amino acid sequences, secondary structures and disulfide bridge frameworks of animal toxins of each reference fold are illustrated in Figure 2 . In the examples shown, only the relative positioning of the secondary structures within the toxin amino acid sequence is conserved. For each type of fold, peptide chain lengths and disulfide bridge organizations can vary depending on the toxin under consideration, as described in later paragraphs. Figure 2 also provides some basic information on the K + channel subtype(s) that is (are) preferentially targeted by the representative toxin examples. In spite of the existence of toxins of different folds, able to recognize various voltage-gated K + channel subtypes, it has been evidenced that these peptides may have in common some key molecular determinants such as the "functional" dyad (Possani et al., 1999b; Dauplais et al., 1997; Mouhat et al., 2003 ) that contributes to blocking efficacy, at least in the case of toxins that act through an ion channel pore blocking mechanism. The position of these key amino acid residues within the toxin primary structure is also pictured in Figure 2 . The typical dyad is composed of a Lys residue entering by its side-chain into the ion channel pore, and an aromatic (Tyr or Phe) or aliphatic (Leu) amino acid residue (Dauplais et al., 1997; Possani et al., 1999b; Gasparini et al., 1998) , separated by a distance of ca. 7 Å. The Lys residue is positioned in the centre of a ring composed by the carbonyl groups of four equivalent acidic residues (Asp or Glu) (M'Barek et al., 2003a; Mouhat et al., 2003; Jouirou et al., 2003) , each belonging to one of the four α-subunits that form a functional K + channel. The critical aromatic or aliphatic residue of the "functional" dyad reportedly interacts -via hydrophobic forces -with a cluster of aromatic residues (Tyr and Trp), generally belonging to a unique K + channel α-subunit. Despite the Ménez, 1998) . It is noteworthy that in κ-PVIIA (βββ), BgK (αα), and dendrotoxin I (3 10 ββα), a triad has been highlighted rather than a dyad (Figure 2 ) (Savarin et al., 1998; Dauplais et al., 1997; Katoh et al., 1999) . In toxins possessing triads, two equivalent hydrophobic residues (e.g., Tyr, Phe or Trp) can functionally substitute to each other to compose, together with the pivotal Lys residue, the actual "functional" dyad. This suggests that toxins displaying triads instead of dyads may possibly adopt more than a single docking position over the ion channel. Of note, the systematic presence of either a dyad or a triad in toxins of unrelated folds suggests that their functional effects could mainly rely on some pore blocking mechanisms (Dauplais et al., 1997) . However, an exception to the rule is provided by scorpion toxin Tc32 (Batista et al., 2002) , which apparently lacks a "functional" dyad but behaves as a potent blocker of a voltage-gated K + channel. In fact, dyads are unlikely to represent the sole molecular determinants of toxins involved in binding to ion channels (Alessandri-Haber et al., 1999) . It has been proposed that a ring of basic residues may also play a pivotal role in this function in line with the concept of a multi-point attachment of the toxin onto its ion channel target (Mouhat et al., 2003; M'Barek et al., 2003a) . Recently, the 3-D structure of the 9-residue contryphan-Vn (PDB code 1N3V), isolated from the venom of the marine cone snail Conus ventricosus, has been reported (Raybaudi-Massilia et al., 2003) . Unlike other K + channel-acting toxins belonging to any of the eight families of toxin fold, contryphan-Vn is folded according to a type IV turn and a type I β-turn that are connected by a unique disulfide bridge. Despite its minimal structure, this toxin also exhibits a dyad (Lys 6 and Trp 8, both located at a proper distance of each other) whose functionality remains to be verified experimentally. Potentially, this toxin structure may thus form a ninth class of toxin folds. et al., 1994; Escoubas et al., 2000) .
Noteworthy, three out of the eight types of fold presented here -βββ, helical hairpin αα and βαββ -are also representative of toxin folds recognizing K + channels (see Figure 1 ) (Rosengren et al., 2002; Barnham et al., 1997; Housset et al., 1994) . Generally, toxins acting on Na + channels (Possani et al., 1999a; Norton, 1991) exhibit increased peptide chain lengths as compared to toxins acting on K + channels. Additionally, they clearly possess more than a unique mechanism of action and can often be classified as gating modifiers. For instance, several different pharmacological sites for toxins have been evidenced on voltage-gated Na + channels (Possani et al., 1999a) . However, only a limited number of experimental data are available to depict the critical amino acid residues involved in the bioactivity of these toxins on Na + channels. This situation probably arises from the difficulty to perform systematic structure-function studies with long chain toxins that are difficult to produce by recombinant or chemical route (Sabatier, 2000) . It has been proposed that these toxins may bind onto their et al., 1999a; Wang et al., 2003; Sun et al., 2003) .
Amino acid sequences, secondary structures and disulfide bridge arrangements of representative animal toxins from each type of fold are pictured in Figure 4 . For each toxin belonging to a particular type of fold, the relative order of secondary structures appearance is conserved. Contrary to short chain animal toxins, only few peptides acting on Na + channels have been fully characterized from the standpoints of 3-D structure and half-cystine pairing pattern (Possani et al., 1999a) . Toxins acting on Na + channels are cross-linked by three to four disulfide bridges. Figure 4 also illustrates that voltage-gated Na + channels are the main targets of the representative toxins.
III-Folds of toxins acting on Ca 2+ channels
Toxins acting on Ca 2+ channels can be classified according to four types of fold ( Figure 5 ). These include peptide folds of the ββ (e.g., bug Ptu1 ( Figure 5a ; Bernard et al.,
2001)), βββ (e.g., cone snail ω-conotoxin GVIA (Figure 5b ; Davis et al., 1993) ), β 1 β 1 β 2 β 2 β 2 (e.g., snake FS2 ( Figure 5c ; Albrand et al., 1995) ), and β 1 ααβ 2 β 1 β 1 β 2 αβ 1 β 1 (e.g., virally encoded fungal toxin KP4 (Figure 5d ; Gu et al., 1995) ) types. Although not produced by an animal species, KP4 was presented here to illustrate the possible structural complexity of some toxins acting on Ca 2+ channels (Gage et al., 2002) . It is the sole toxin also reported to contain α-helical structures apart from β-sheets. From the various folds, three toxin architectures can be distinguished: ICK (ββ or βββ), three-finger (β 1 β 1 β 2 β 2 β 2 ) (Kini, 2002) , and α/β sandwich (β 1 ααβ 2 β 1 β 1 β 2 αβ 1 β 1 ). The ββ type of fold is common to some toxins acting on Na + channels (Peng et al., 2002) , whereas the βββ type is common to some toxins specific for either K + or Na + channels (Scanlon et al., 1997; Rosengren et al., 2002 Therefore, three-finger toxins display three β-stranded loops that extend from a central core containing the four conserved disulfide bridges. Of note, the three-fingered fold is not limited to elapid or hydrophid toxins. Owing to the relative complexity of the fold associated to the α/β sandwich motif (Gu et al., 1995) , one can anticipate the existence of other types of fold for toxins acting on Ca 2+ channels. For instance, the 63-residue kurtoxin (Chuang et al., 1998) isolated from the scorpion Parabuthus transvaalicus and acting on low voltage-gated Ca 2+ channels shares marked structural similarities with scorpion α-toxins (Possani et al., 1999a) acting on Na + channels (βαββ type) and is expected to fold according to the α/β scaffold. If confirmed experimentally, kurtoxin would represent the first member of an additional family of toxin folds. Interestingly, the marine cone snail ω-conotoxin GVIA (Davis et al., 1993) , which acts as an ion channel pore blocker, also contains a "functional" dyad composed of Lys 2 and Tyr 13 (Flinn et al., 1999) that is similar to those of K + channel-acting toxins (Dauplais et al., 1997) . Not all toxins active on Ca 2+ channels are pore blockers, and many were found to affect ion channel gating properties as well. Again, this is the case for kurtoxin that slows down the inactivation rates of both voltage-gated Ca 2+ and Na + channels (Chuang et al., 1998) . The cross-reactivity of kurtoxin is of interest and further suggests that the βαββ type of fold is common to certain toxins that may act on K + , Na + or/and Ca 2+ channels. This is also valid for scorpion chlorotoxin (Lippens et al., 1995) that reportedly acts on Cl -channels (see next section). This observation suggests a remarkable adaptation of this family of toxin folds to ion channels of different ionic selectivity. Some key structural features of the reference toxins are provided in Figure 6 . Note that the number of toxin disulfide bridges varies from three to five. Biological targets shown here are voltage-gated Ca 2+ channels, but endoplasmic (Fajloun et al., 2000a) .
IV-Fold of toxins acting on Cl -channels
A unique toxin fold (βαββ) has been described hitherto for scorpion 36-residue chlorotoxin (Lippens et al., 1995) (Figure 7 ) and 35-residue Bm-12 (Wu et al., 2000) . These short chain toxins are cross-linked by four disulfide bridges and display the classical α/β scaffold (Bontems et al., 1991) . The poverty of characterized toxins acting on Cl -channels must be due to the fact that only few pharmacological studies have focused on these channels.
V-Toxin folds and disulfide bridge frameworks
Animal toxins not only possess well-defined folds, but are also highly reticulated peptides with regard to their size. Toxin disulfide bridges vary in number from two to five. The halfcystine pairings of the toxin contribute to the stabilization and rigidity of its fold. Indeed, the resulting reduction in toxin backbone flexibility is thought to increase the efficacy of channel modulation through strict spatial positioning of toxin residues that are key to ion channel interaction. A disulfide bridge pattern of a toxin is not necessarily linked to a particular type of fold and vice versa. For instance, sea anemone ShK from Stichodactyla heliantus (Tudor et al., 1996) , BgK from Bunodosoma granulifera (Dauplais et al., 1997) and snake dendrotoxin I from Dendroaspis polylepis (Lancelin et al., 1994) , all acting on K + channels, exhibit similar C1-C6, C2-C4 and C3-C5 half-cystine pairing patterns although they fold differently (3 10 αα, αα and 3 10 ββα types, respectively). For three-disulfide-bridged toxins of various animal species, all acting on different ion channel targets, an identical pattern of disulfide bridges can be found, indicating that peptide reticulation is independent from the animal species, biological target and et al., 1992) , and (iii) the marine cone snail ω-conotoxin GVIA acting on Ca 2+ channels possesses a βββ type of fold also with an ICK motif (Davis et al., 1993) .
The same observation is valid for toxins reticulated by four disulfide bridges, e.g., C1-C4, C2-C6, C3-C7 and C5-C8 : (i) the spider δ-atracotoxin-Hv1 acting on Na + channels shows an helical ended βββ3 10 type of fold with an ICK motif (Fletcher et al., 1997) , whereas (ii) the scorpion chlorotoxin acting on Cl -channels displays a βαββ type of fold with an α/β scaffold (Lippens et al., 1995) . Conversely, for a defined toxin architectural motif, several patterns of disulfide bridging may occur. For example, in the case of the ICK motif, the following peptide reticulations have been demonstrated: (i) C1-C4, C2-C5 and C3-C6 (ω-conotoxin GVIA, hanatoxin 1, κ-PVIIA, and huwentoxin-IV), (ii) C1-C4, C2-C6, C3-C7 and C5-C8 (δ-atracotoxin-Hv1), and (iii) C1-C4, C2-C5, C3-C8 and C6-C7 (ACTX-Hi:OB4219). Another example deals with Pi1 (Olamendi-Portugal et al., 1996) and maurotoxin (Kharrat et al., 1996) , two scorpion toxins (α-KTx6 family) that possess an α/β scaffold, but that differ in their disulfide bridge arrangements (C1-C5, C2-C6, C3-C7 and C4-C8 versus C1-C5, C2-C6, C3-C4
and C7-C8, respectively) (Fajloun et al., 2000b; M'Barek et al., 2003b) . Of note, the helical hairpin (αα) toxin fold is obligatorily linked to a specific disulfide bridge organization (e.g., C1-C4 and C2-C3 in the case of the two-disulfide-bridged scorpion κ-hefutoxin 1 (Srinivasan et al., 2002) , and C1-C8, C2-C7, C3-C6 and C4-C5 in the case of the four disulfide-bridged marine worm toxin B-IV (Barnham et al., 1997) ) display only a few conserved structural motifs that are -according to their particular patterns of half-cystine arrangements -referred to as: (i) the four cysteine/two-loop framework (CC-C-C) that comprises the α-conotoxins targeting nicotinic acetylcholine receptor, (ii) the six cysteine/three-loop framework (CC-C-C-CC) that comprises the µ-conotoxins acting on Na + channels, and (iii) the six cysteine/four-loop framework with two variants, C-C-CC-C-C (the most abundant of all frameworks) comprising δ-, ω-(e.g., ω-GVIA) and κ-conotoxins (e.g., κ-PVIIA) targeting Na + , Ca 2+ and K + channels, respectively, and CC-C-C-C-C comprising µ-PnIVA/B targeting Na + channels (Hill et al., 2000) .
VII-Concluding remarks and perspectives
Here, we surveyed the various types of fold of animal toxins able to recognize, bind to, and modulate ion channels of different ionic selectivity. To date, we estimate that animal toxins could be classified along anyone of the fourteen different families of toxin folds.
Considering the tremendous number of toxins that remain to be structurally characterized from the venoms of the diverse animal species, we would reasonably expect the number of different toxin folds to increase dramatically in the forthcoming years. Indeed, it is observed provided a greater number of peptide folds. However, this observation would rather result from an historic bias since the venoms of some specific animal species have been far more studied than others. The main reasons for such a bias are the ease at which the venom can be collected together with the quantity of material produced, along with considerations such as national sanitary politics, economic value, etc… It is more likely that none of the toxin folds can be definitively associated to a defined animal species. What emerges conclusively from our structural analysis of animal toxins is that peptides that possess a similar type of fold can exert their action on several types of ion channels; the most representative examples being provided by peptides belonging to the large family of conotoxins (e.g., κ-PVIIA and ω-conotoxin GVIA). Other representative examples are scorpion kurtoxin (Chuang et al., 1998) and kurtoxin-like I (KLI) peptides (Olamendi-Portugal et al., 2002) that are active on both voltage-gated Na + and T-type Ca 2+ channels. These examples of cross-reactivity might represent the rule rather than the exception. Indeed, most toxins are characterized on a limited number of pharmacological targets, underscoring that many other true physiological targets remain to be discovered (Delepierre et al., 1999) . However, it should be noted that we were so far unable to point to a group of toxins sharing the same fold and able to modulate the four types of ion channels considered here. We assume that this is just a matter of time as the list of characterized toxins is growing exponentially. Conversely, it is now clear that a particular ion channel can be target by toxins that possess unrelated folds. The latter in mind, one should note that action of toxins of unrelated folds on the same channel potentially implicate distinct interaction sites. This is at least expected for toxins differing in their modes of action, e.g., ion channel pore blockers versus gating modifiers. The ability of structurally divergent toxins to recognize a particular ion channel relies on the equivalent spatial distribution of amino acid et al., 1996) .
Finally, there is no striking correlation between toxin folds, disulfide bridge frameworks, and pharmacology. Where the folds and disulfide bridge organizations play crucial roles are in the spatial distribution of residues key to toxin pharmacology.
Improvement of ion channel recognition by toxins (selectivity, affinity, potency) can be achieved through slight or marked alterations of toxin structures (Sabatier et al., 1993 ; Shakkottai et al., 2001) . Therefore, more structure-activity relationship studies on animal toxins will be required to detail the intimate molecular basis of toxin to ion channel
interaction. This appears as immediate and important issues with regard to the therapeutic potential of toxins and structural analogs thereof for producing immunosuppressant agents Savarin, P., Guenneugues, M., Gilquin B., Lamthanh, H., Gasparini, S., Zinn-Justin, S., Ménez A., 1998. Three-dimensional structure of κ-conotoxin PVIIA, a novel potassium channel-blocking toxin from cone snails. Biochemistry 37, 5407-5416. 
